InvestorsHub Logo
Followers 6
Posts 1066
Boards Moderated 0
Alias Born 11/11/2014

Re: KevinDU post# 20890

Saturday, 03/07/2015 6:38:28 AM

Saturday, March 07, 2015 6:38:28 AM

Post# of 140478
That's good for TRXC but even he can't shine that pig. For every super mega success frost has had,it seems he's had equal or more failures. TRXC is just another gamble for him and a relatively cheap one for him.


From seeking alpha:

But our research into Dr. Frost's background shows that while he has had some successes over his forty years as a pharma executive, his investment acumen leaves much to be desired. In fact, looking over his recent investment record, we find that he invested heavily in a fraudulent Chinese company and in numerous other pharmaceutical companies whose shares have subsequently fallen dramatically. Given Dr. Frost's flawed investment record, we think it is rather odd that the market would assign a nearly billion dollar premium to Opko's valuation merely due to Dr. Frost's repeated share purchases. If anything, investors should apply a discount to Opko's shares, given Frost's questionable public investing track record.